SUNLENCA 464 mg, solution injectable — 2 flacon(s) en verre de 1,5 ml + 2 adaptateur(s) pour flacon + 2 seringue(s) + 2 aiguille(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930258064 -
CIP7
3025806 -
CIS
65950064 -
Registration number
EU/1/22/1671
What the source publishes
- Holder
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Active ingredients
- LÉNACAPAVIR, LÉNACAPAVIR SODIQUE
- Form
- solution injectable
- Package
- 2 flacon(s) en verre de 1,5 ml + 2 adaptateur(s) pour flacon + 2 seringue(s) + 2 aiguille(s)
- Routes
- sous-cutanée
- Administrative status
- authorised
- Supply regime
- prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2022-08-17
- Prescription
- Prescription or restricted
Names this record is found by
- SUNLENCA 464 mg, solution injectable — 2 flacon(s) en verre de 1,5 ml + 2 adaptateur(s) pour flacon + 2 seringue(s) + 2 aiguille(s)
- SUNLENCA 464 mg, solution injectable
- LÉNACAPAVIR
- LÉNACAPAVIR SODIQUE
Complete source data
{
"cis": "65950064",
"cip7": "3025806",
"form": "solution injectable",
"name": "SUNLENCA 464 mg, solution injectable — 2 flacon(s) en verre de 1,5 ml + 2 adaptateur(s) pour flacon + 2 seringue(s) + 2 aiguille(s)",
"cip13": "3400930258064",
"holder": "GILEAD SCIENCES IRELAND UC (IRLANDE)",
"routes": [
"sous-cutanée"
],
"holders": [
"GILEAD SCIENCES IRELAND UC (IRLANDE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "21131.79",
"authorisedOn": "2022-08-17",
"compositions": [
{
"name": "LÉNACAPAVIR",
"nature": "FT",
"strength": "464 mg",
"linkageNumber": "1",
"substanceCode": "67021",
"dosageReference": "1,5 mL de solution",
"pharmaceuticalElement": "solution"
},
{
"name": "LÉNACAPAVIR SODIQUE",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "86126",
"dosageReference": null,
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
"dispensingFee": "1.02",
"medicinePrice": "21130.77",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SUNLENCA 464 mg, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "2 flacon(s) en verre de 1,5 ml + 2 adaptateur(s) pour flacon + 2 seringue(s) + 2 aiguille(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2022-12-20",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"LÉNACAPAVIR",
"LÉNACAPAVIR SODIQUE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription initiale hospitalière annuelle",
"liste I",
"renouvellement non restreint"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/22/1671",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930258064"